健康经济学简介。
A brief introduction to health economics.
机构信息
Division of Health Sciences, Warwick Medical School, University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK.
出版信息
Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):1704-1707. doi: 10.1007/s00167-019-05372-y. Epub 2019 Feb 7.
Abstract
To convince policy-makers or funders of health care of the value of orthopaedic interventions, we need to consider value for money (cost-effectiveness), as well as clinical effectiveness. This article provides an introduction to health economics to set the scene for papers on the use of allografts in the knee.
摘要
为了让医疗保健政策制定者或资助者相信矫形干预的价值，我们不仅需要考虑临床效果，还要考虑资金的使用效率（成本效益）。本文介绍了健康经济学，为有关膝关节同种异体移植物使用的论文奠定了基础。
相似文献
1
A brief introduction to health economics.健康经济学简介。
Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):1704-1707. doi: 10.1007/s00167-019-05372-y. Epub 2019 Feb 7.
2
The economics of minimally invasive spine surgery: the value perspective.微创脊柱手术的经济学：价值视角。
Spine (Phila Pa 1976). 2010 Dec 15;35(26 Suppl):S375-82. doi: 10.1097/BRS.0b013e31820238d9.
3
Cost-utility analyses in orthopaedic surgery.骨科手术中的成本效用分析。
J Bone Joint Surg Am. 2005 Jun;87(6):1253-9. doi: 10.2106/JBJS.D.02152.
4
Cost-Effectiveness Analyses in Orthopaedic Surgery: Raising the Bar.骨科手术中的成本效益分析：提高标准。
J Bone Joint Surg Am. 2017 Jul 5;99(13):e71. doi: 10.2106/JBJS.17.00509.
5
Cost-effectiveness analyses of elective orthopaedic surgical procedures in patients with inflammatory arthropathies.择期矫形外科手术治疗炎性关节病患者的成本效益分析。
Scand J Rheumatol. 2011 Mar;40(2):108-15. doi: 10.3109/03009742.2010.503661. Epub 2011 Jan 17.
6
Value of Pediatric Orthopaedic Surgery.小儿骨科学手术的价值。
J Pediatr Orthop. 2015 Jul-Aug;35(5 Suppl 1):S9-13. doi: 10.1097/BPO.0000000000000536.
7
Cost-effectiveness studies: who is the key stakeholder?成本效益研究：关键利益相关者是谁？
Bone Joint J. 2019 Nov;101-B(11):1321-1324. doi: 10.1302/0301-620X.101B11.BJJ-2019-0954.
8
The cost-effectiveness of osteochondral allograft transplantation in the knee.膝关节骨软骨同种异体移植的成本效益。
Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):1739-1753. doi: 10.1007/s00167-019-05392-8. Epub 2019 Feb 5.
9
In Brief: cost-effectiveness analyses in orthopaedics.简而言之：骨科的成本效益分析。
Clin Orthop Relat Res. 2011 Aug;469(8):2395-8. doi: 10.1007/s11999-011-1873-3.
10
Guest Editorial: Is There Value in Value-based Health Care?客座编辑评论：基于价值的医疗保健是否有价值？
Clin Orthop Relat Res. 2019 Feb;477(2):265-267. doi: 10.1097/CORR.0000000000000617.
引用本文的文献
1
Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research.基于真实世界研究的重组人血小板生成素和重组人白细胞介素-11治疗癌症治疗所致血小板减少症的有效性及经济学评价
Front Pharmacol. 2024 Jan 23;15:1288964. doi: 10.3389/fphar.2024.1288964. eCollection 2024.
2
Allografts in joint reconstruction: ESSKA making a difference.关节重建中的同种异体移植：欧洲运动创伤、膝关节镜与关节外科学会正在发挥作用。
Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):1701-1703. doi: 10.1007/s00167-019-05514-2. Epub 2019 May 10.
本文引用的文献
1
Autologous chondrocyte implantation in the knee: systematic review and economic evaluation.膝关节自体软骨细胞移植：系统评价与经济学评估
Health Technol Assess. 2017 Feb;21(6):1-294. doi: 10.3310/hta21060.
2
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.英国国家卫生与临床优化研究所成本效益阈值的估计方法。
Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.
3
Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D.建立骨关节炎指数（WOMAC）与欧洲五维度健康量表（EQ-5D）之间的关系模型。
Health Qual Life Outcomes. 2014 Mar 12;12:37. doi: 10.1186/1477-7525-12-37.
4
The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in Belgium.在比利时，使用 ChondroCelect® 进行自体软骨细胞移植治疗症状性膝关节软骨损伤的成本效用分析。
Pharmacoeconomics. 2010;28(12):1129-46. doi: 10.2165/11584920-000000000-00000.
5
Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index.使用特定疾病的工具进行经济评估：将 WOMAC 映射到 EQ-5D 效用指数上。
Value Health. 2010 Dec;13(8):873-8. doi: 10.1111/j.1524-4733.2010.00770.x.
6
Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?基于EQ-5D的成本效用估计与基于效用分数映射的估计有差异吗？
Health Qual Life Outcomes. 2008 Jul 14;6:51. doi: 10.1186/1477-7525-6-51.
7
The development and validation of a quality of life-measurement tool for patients with meniscal pathology: the Western Ontario Meniscal Evaluation Tool (WOMET).半月板病变患者生活质量测量工具的开发与验证：西安大略半月板评估工具（WOMET）。
Clin J Sport Med. 2007 Sep;17(5):349-56. doi: 10.1097/JSM.0b013e31814c3e15.
8
The estimation of a preference-based measure of health from the SF-36.基于SF-36量表对健康偏好测量值的估计。
J Health Econ. 2002 Mar;21(2):271-92. doi: 10.1016/s0167-6296(01)00130-8.
9
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties.西安大略和麦克马斯特大学骨关节炎指数（WOMAC）：对其效用和测量特性的综述
Arthritis Rheum. 2001 Oct;45(5):453-61. doi: 10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w.
10
EuroQol: the current state of play.欧洲生活质量量表：当前进展情况
Health Policy. 1996 Jul;37(1):53-72. doi: 10.1016/0168-8510(96)00822-6.
Zotero 插件